EQUITY RESEARCH MEMO

Exactech

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

Exactech, a privately held medical device company headquartered in Gainesville, Florida, specializes in the development and marketing of orthopedic implants, surgical instrumentation, and smart technologies for joint replacement surgery. Founded in 1985, the company operates exclusively through a business-to-business model, supplying hospitals and surgeons rather than selling directly to consumers. Its product portfolio includes hip, knee, and shoulder implants, as well as advanced digital tools like the ExactechGPS® surgical planning and navigation system, which leverages artificial intelligence to enhance surgical precision and patient outcomes. With a focus on innovation and clinical evidence, Exactech has established a strong reputation in the orthopedic market, competing against larger players such as Stryker and Zimmer Biomet. The company's commitment to smart technology integration positions it well to capitalize on the growing demand for personalized, data-driven orthopedic care. Looking ahead, Exactech is poised to benefit from favorable demographic trends, including an aging population and increasing prevalence of osteoarthritis, which drive demand for joint replacement procedures. The company continues to expand its product offerings and geographical reach, particularly in international markets. However, it faces challenges such as pricing pressure, regulatory scrutiny, and competition from established and emerging players. Exactech's private status allows it to focus on long-term strategic goals without quarterly earnings pressure, but it also limits access to public capital markets. Overall, the company's strong product pipeline, emphasis on digital surgery, and loyal surgeon customer base support a positive outlook for steady growth.

Upcoming Catalysts (preview)

  • Q4 2026FDA Clearance for Next-Generation Smart Knee Replacement System70% success
  • Q2 2027Expansion of ExactechGPS Platform into Shoulder Arthroplasty Indication60% success
  • TBDStrategic Partnership with Major Hospital Network for Digital Surgery Adoption50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)